Collegium Pharmaceutical (COLL) Treasury Shares (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Treasury Shares of $222.5 million for Q1 2026, up 12.66% year-over-year from $197.5 million in Q1 2025, and little changed quarter-over-quarter from $222.5 million in Q4 2025.
Collegium Pharmaceutical (COLL) Treasury Shares (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Treasury Shares history runs 9 years deep, the most recent figure standing at $222.5 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 12.66% year-over-year to $222.5 million; the TTM figure through Mar 2026 stood at $222.5 million (up 12.66% YoY), while the FY2025 annual figure was $222.5 million, up 12.66% from the prior year.
- Treasury Shares for Q1 2026 stood at $222.5 million, roughly flat from $222.5 million in the prior quarter.
- The five-year high for Treasury Shares was $9.0 million in Q3 2025, with the low at $2.5 million in Q1 2022.
- The 5-year median for Treasury Shares is $6.3 million (2023), against an average of $6.0 million.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares surged 1138.48% in 2023, then advanced 12.66% in 2025.
- Collegium Pharmaceutical's Treasury Shares stood at $61.9 million in 2022, then surged by 121.85% to $137.4 million in 2023, then jumped by 43.76% to $197.5 million in 2024, then increased by 12.66% to $222.5 million in 2025, then changed by 0.0% to $222.5 million in 2026.
- Business Quant data shows COLL's Treasury Shares at $222.5 million in Q1 2026, $222.5 million in Q4 2025, and $222.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 19.00 Mn |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn | 9.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.03 Mn |
| Jun 30, 2026 | 9.03 Mn |
| Jun 30, 2026 | 222.51 Mn |
| Jun 30, 2026 | 222.51 Mn |
| Mar 31, 2026 | 9.03 Mn |
| Mar 31, 2026 | 222.51 Mn |
| Mar 31, 2026 | 222.51 Mn |
| Mar 31, 2026 | 9.03 Mn |
| Dec 31, 2025 | 222.51 Mn |
| Dec 31, 2025 | 9.03 Mn |
| Dec 31, 2025 | 9.03 Mn |
| Dec 31, 2025 | 222.51 Mn |
| Sep 30, 2025 | 222.51 Mn |
| Sep 30, 2025 | 9.03 Mn |
| Sep 30, 2025 | 222.51 Mn |
| Sep 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Jun 30, 2025 | 217.51 Mn |
| Jun 30, 2025 | 217.51 Mn |
| Jun 30, 2025 | 8.90 Mn |